British American Tobacco plc stock (GB0002875804): earnings reset and strategy shift keep investors watching

British American Tobacco is digesting a major US brand impairment while pushing into non?combustible products. Recent full?year results and a new CEO are reshaping the story for one of the world’s largest tobacco groups.

British American Tobacco plc is in the middle of a far?reaching transition: after a multibillion?pound impairment on parts of its US cigarette portfolio, the group is sharpening its focus on so?called reduced?risk products and has outlined new financial targets with its latest annual results, according to a statement published on 02/08/2024 by the company.

As of: 05/24/2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: BAT
• Sector/industry: Tobacco and nicotine products
• Headquarters/country: London, United Kingdom
• Core markets: United States, Europe, Asia-Pacific, Latin America, Africa
• Key revenue drivers: Combustible cigarettes, heated tobacco, vaping and modern oral nicotine
• Home exchange/listing venue: London Stock Exchange (ticker: BATS); ADR on NYSE (ticker: BTI)
• Trading currency: GBP in London, USD for the ADR

British American Tobacco plc: core business model

British American Tobacco plc is one of the world’s largest tobacco groups, generating most of its revenue from cigarettes while increasingly investing in non?combustible products such as vapes, heated tobacco and oral nicotine pouches. The group owns global cigarette brands including Dunhill, Lucky Strike, Pall Mall and Rothmans as well as a portfolio of local and regional brands.

The company organizes its operations across multiple geographic regions, with a significant portion of profit coming from developed markets such as the United States and Western Europe. After acquiring Reynolds American in 2017, British American Tobacco gained a strong foothold in the US cigarette and oral tobacco market, particularly through brands such as Newport and Camel. That transaction has shaped the earnings profile and debt structure of the group in recent years.

Alongside traditional cigarettes, management has identified three strategic “new categories”: vaping products under brands like Vuse, heated tobacco sticks sold under the glo brand, and modern oral nicotine pouches marketed under names such as Velo. The company aims for these non?combustible products to offset long?term volume declines in cigarettes and contribute a rising share of group revenue and profit as regulatory and consumer trends shift.

In its full?year 2023 results, British American Tobacco reported group revenue of around GBP 27 billion for the year ended 12/31/2023, with reported operating profit heavily affected by a non?cash impairment of certain US cigarette and vapor brands, according to the company’s results release dated 02/08/2024 BAT results release as of 02/08/2024. Excluding that charge, the group highlighted growth in adjusted revenue and profit, particularly from its new category portfolio, which management stated was moving closer to profitability.

The business model is therefore based on a dual track: sustaining cash flows from traditional combustible products, which remain highly profitable but face structural volume decline and regulatory pressure, while scaling up non?combustible products that may offer lower regulatory risk and appeal to adult consumers switching away from cigarettes. For investors, this balance between legacy cash generation and future?oriented categories is central to how British American Tobacco is valued and perceived in the market.

Main revenue and product drivers for British American Tobacco plc

Cigarettes remain the core driver of revenue and earnings. In 2023, combustible products still accounted for the majority of group revenue, with price increases and mix improvement offsetting volume declines in many markets, according to the same full?year 2023 communication released on 02/08/2024 BAT investor information as of 02/08/2024. The company emphasized that premium and global brand families continued to gain share in several key regions, supporting profitability.

New categories have been growing quickly from a smaller base. Management reported that revenue from vaping, heated tobacco and modern oral products reached several billion pounds in 2023, with a target to reach profitability for these categories by 2024 on an adjusted basis, as outlined in the February 2024 results release. Vuse is positioned as a leading closed?system vape brand in several markets, while glo competes with other heated tobacco systems by offering consumable sticks that generate recurring revenue.

In the United States, the group’s performance is shaped by menthol, premium and value cigarette segments as well as oral nicotine. The 2023 impairment of US cigarette and vapor brands, which management valued at around GBP 27 billion in non?cash charges, reflects revised long?term assumptions about that market’s regulatory and demand outlook. Despite this accounting impact, the company stated that it still expects strong cash generation and maintained its progressive dividend policy for shareholders in the same announcement dated 02/08/2024.

Outside the US, British American Tobacco’s presence in emerging markets such as South Asia, Africa and parts of Latin America offers volume growth potential, though often at lower price points and with currency volatility. In developed regions such as Western Europe and Japan, the key revenue determinants are price discipline, brand strength and adoption of reduced?risk products. The combination of geographic diversification and category expansion is intended to mitigate individual market risks.

For US investors following the American depositary receipts listed on the New York Stock Exchange under the ticker BTI, the main financial drivers include the group’s sterling?denominated earnings translated into dollars, the level and growth of the cash dividend, debt metrics following the Reynolds acquisition, and the trajectory of reduced?risk product profitability. Currency movements between the British pound and the US dollar can significantly influence the dollar value of dividends and reported earnings for ADR holders.

Why British American Tobacco plc matters for US investors

Although British American Tobacco is headquartered in the United Kingdom, it has a deep footprint in the US tobacco market and its ADRs trade actively on the New York Stock Exchange. That makes the stock part of the global consumer staples universe considered by many US investors who seek income and exposure to cash?generative businesses.

From a portfolio perspective, the company offers characteristics typical of the tobacco sector: significant cash generation, high operating margins and a history of paying regular dividends. The company’s 2023 results communication reiterated its commitment to a dividend policy of progressive or stable dividends in sterling terms, subject to board approval, as noted in the release dated 02/08/2024. For US investors, the yield on the ADRs can therefore be a central element of the investment case, alongside the underlying earnings trend.

However, US investors also need to weigh the sector?specific risks. Tobacco companies operate under stringent and evolving regulation, including advertising bans, plain packaging measures, flavor restrictions and the possibility of increased excise taxation. In the United States, debate about menthol cigarette rules and flavored vapor products has been particularly important for companies with that product exposure. These regulatory dynamics can affect the long?term sustainability of earnings from both combustible and non?combustible categories.

In addition, because British American Tobacco reports its primary financials in pounds, US investors face currency risk. A weaker pound can support the dollar value of reported earnings when converted, but it can also reflect broader macroeconomic challenges in the home market. The level of leverage following the Reynolds acquisition and the company’s plans for deleveraging through cash flow generation are also closely watched by bondholders and equity investors alike in the US market.

Risks and open questions

The impairment of US cigarette and vapor brands recorded in 2023 underscores the uncertainty about long?term consumption patterns for nicotine products in developed markets. While this impairment was non?cash, it signals management’s more cautious assumptions around future volumes and pricing for certain brands, as stated in the company’s 02/08/2024 communication. It raises the question of whether additional adjustments could be required if regulatory or consumer trends evolve more quickly than currently expected.

Regulation remains a central risk. In many markets, governments are exploring stricter measures on nicotine products, including potential phase?out plans, minimum pricing, display restrictions and new health warnings. In the vapor category, product authorization processes and limitations on flavors can materially affect the competitive landscape. For British American Tobacco, any sudden regulatory change in key markets such as the US, EU or China?influenced jurisdictions could necessitate changes to strategy and impact volumes.

Litigation is another factor. Tobacco companies have historically faced lawsuits related to health impacts, marketing practices and product liability. While the legal environment has evolved compared with earlier decades, the potential for large settlements or new legal challenges remains. Moreover, as new categories like vapes and nicotine pouches gain scale, they too could become the subject of litigation or targeted regulation, adding complexity to the risk profile.

Finally, investor perception of environmental, social and governance (ESG) factors adds an additional layer of uncertainty. Some institutional investors have policies that limit or exclude exposure to tobacco manufacturers, which can affect the shareholder base and potentially valuation metrics. The extent to which British American Tobacco can position its non?combustible portfolio as reducing harm relative to traditional cigarettes, while providing transparent data and meeting regulatory expectations, is likely to influence future ESG assessments and capital market access.

Conclusion

British American Tobacco plc stands at a turning point: the sizeable non?cash impairment booked in 2023 has reset expectations for part of its US cigarette and vapor franchise, while the company places increasing emphasis on new categories such as vapes, heated tobacco and oral nicotine. Its latest full?year results, published on 02/08/2024, illustrate both sides of the story: resilient underlying cash generation and dividend capacity, but also the challenges of operating in a sector facing structural volume decline and intense regulatory scrutiny. For US investors accessing the stock through the BTI ADRs on the New York Stock Exchange, the key themes to monitor include the pace at which reduced?risk products move to sustainable profitability, the evolution of US and global nicotine regulation, the company’s deleveraging progress and the stability of its dividend in sterling terms. How these elements interact is likely to shape sentiment toward the stock more than any single quarter’s earnings print.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.